EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke

Alicia Sierra-Gómez iD, María Esther Ramos-Araque, Sven P R Luijten, Mercedes de Lera Alfonso, Ana Calleja, Gonzalo Valle-Peñacoba, Beatriz Gómez-Vicente, Javier Reyes, Mario Martínez-Galdámez, Jorge Galván, Miguel Schüller-Arteaga, Lorenzo Pérez Sánchez und 2 weitere

European Journal of Neurology · 2025

DOI: 10.1111/ene.16509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Alicia Sierra-Gómez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid Health Research Institute, Valladolid, Spain. Hauptthemen laut MEDLINE: Intracranial Arteriosclerosis, Ischemic Stroke, Endovascular Procedures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose The influence of intracranial arteriosclerosis (ICAR) on acute ischaemic stroke (AIS) prognosis is unclear. This study explored its impact, focusing on ICAR subtypes categorized by intracranial carotid artery calcification (ICAC) patterns: intimal or atherosclerotic versus internal elastic lamina calcification or non‐atherosclerotic. The aim was to determine their effect on AIS prognosis in patients undergoing endovascular treatment (EVT).

Methods

This prospective cohort study included consecutive AIS patients with anterior circulation large vessel occlusion undergoing EVT. ICAC, the hallmark of ICAR, was assessed using non‐contrast computed tomography to quantify volume and establish the predominant ICAR subtype. The primary outcome was long‐term functional outcome, measured by the 90‐day modified Rankin Scale score. Secondary outcomes included first‐pass effect, revascularization degree, symptomatic intracranial haemorrhage and 24‐h infarct volume. Multivariate‐adjusted linear and logistic regression models were used to assess the association of ICAC volume and subtype with these outcomes.

Results

From January 2021 to February 2022, 181 patients were included, of whom 172 (95%) had ICAC. Internal elastic lamina calcification was the predominant subtype in 103 (57%), intimal in 52 (29%) and mixed in 17 (9%). The intimal or atherosclerotic ICAC pattern was linked to poorer functional outcomes (adjusted odds ratio 2.12, 95% confidence interval [CI] 1.10–4.09), decreased first‐pass effect probability (adjusted odds ratio 0.42, 95% CI 0.21–0.84) and higher infarct volume (adjusted β value 22.11, 95% CI 0.55–43.67).

Conclusions

A predominant intimal ICAC subtype, linked to underlying atherosclerosis, correlated with larger infarct volume and poorer 90‐day functional outcomes in EVT‐treated AIS patients. Intracranial atherosclerosis appears to be a relevant factor hampering clinical benefits post‐EVT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracranial ArteriosclerosisIschemic StrokeEndovascular ProceduresHumansMaleFemaleAgedMiddle AgedPrognosisProspective StudiesAged, 80 and overCohort StudiesVascular Calcification

Stichwörter der Autor:innen

acute ischaemic strokeendovascular treatmentinternal elastic lamina calcificationintimal calcificationintracranial arteriosclerosisintracranial atherosclerosisintracranial carotid artery calcification

Autor:innen und Institutionen

  • Department of Neurology, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid Health Research Institute, Valladolid, Spain.
  • Department of Neurology, Complejo Asistencial Universitario de Salamanca, Instituto de investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
  • Department of Radiology and Nuclear Medicine, Erasmus MC, The Netherlands.
  • Department of Radiology and Nuclear Medicine, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid, Spain.
  • Department of Epidemiology, Erasmus MC, The Netherlands.
  • Department of Medicine, Clinical Neurosciences Research Group, University of Valladolid, Valladolid, Spain.

ORCID-Profile: Alicia Sierra-Gómez, Daniel Bos

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Sierra-Gómez, A., Ramos-Araque, M. E., Luijten, S. P. R., de Lera Alfonso, M., Calleja, A., Valle-Peñacoba, G., Gómez-Vicente, B., Reyes, J., Martínez-Galdámez, M., Galván, J., Schüller-Arteaga, M., Sánchez, L. P., Bos, D., & Arenillas, J. F. (2025). Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke. European Journal of Neurology. https://doi.org/10.1111/ene.16509

Vancouver

Sierra-Gómez A, Ramos-Araque ME, Luijten SPR, de Lera Alfonso M, Calleja A, Valle-Peñacoba G, et al. Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke. European Journal of Neurology. 2025. doi:10.1111/ene.16509

BibTeX
@article{SierraGmez2025,
  author = {Sierra-Gómez, Alicia and Ramos-Araque, María Esther and Luijten, Sven P R and de Lera Alfonso, Mercedes and Calleja, Ana and Valle-Peñacoba, Gonzalo and Gómez-Vicente, Beatriz and Reyes, Javier and Martínez-Galdámez, Mario and Galván, Jorge and Schüller-Arteaga, Miguel and Sánchez, Lorenzo Pérez and Bos, Daniel and Arenillas, Juan F},
  title = {Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.16509}
}
Kostenlos starten →